Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
11 |
Material Type: Article
|
![]() |
Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery studyPlaze, M ; Attali, D ; Petit, A-C ; Blatzer, M ; Simon-Loriere, E ; Vinckier, F ; Cachia, A ; Chrétien, F ; Gaillard, REncéphale, 2020-06, Vol.46 (3S), p.S35 [Peer Reviewed Journal]FranceFull text available |
12 |
Material Type: Article
|
![]() |
Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine TrialsHuang, Ying ; Gilbert, Peter B. ; Wolfson, JulianBiometrics, 2013-06, Vol.69 (2), p.301-309 [Peer Reviewed Journal]United States: Blackwell Publishing LtdFull text available |
13 |
Material Type: Article
|
![]() |
Global rank tests for multiple, possibly censored, outcomesRamchandani, Ritesh ; Schoenfeld, David A. ; Finkelstein, Dianne M.Biometrics, 2016-09, Vol.72 (3), p.926-935 [Peer Reviewed Journal]United States: Blackwell Publishing LtdFull text available |
14 |
Material Type: Article
|
![]() |
Analysis of Longitudinal Clinical Trials with Missing Data Using Multiple Imputation in Conjunction with Robust RegressionMehrotra, Devan V. ; Li, Xiaoming ; Liu, Jiajun ; Lu, KaifengBiometrics, 2012-12, Vol.68 (4), p.1250-1259 [Peer Reviewed Journal]Malden, USA: Blackwell Publishing IncFull text available |
15 |
Material Type: Article
|
![]() |
Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndromeChen, Ming‐Hui ; Ibrahim, Joseph G ; Zeng, Donglin ; Hu, Kuolung ; Jia, CatherineBiometrics, 2014-12, Vol.70 (4), p.1003-1013 [Peer Reviewed Journal]United States: International Biometric Society, etc.Full text available |
16 |
Material Type: Article
|
![]() |
What can we expect from clinical trials in psychiatry?Marsot, A ; Boucherie, Q ; Kheloufi, F ; Riff, C ; Braunstein, D ; Dupouey, J ; Guilhaumou, R ; Zendjidjian, X ; Bonin-Guillaume, S ; Fakra, E ; Guye, M ; Jirsa, V ; Azorin, J-M ; Belzeaux, R ; Adida, M ; Micallef, J ; Blin, OEncéphale, 2016-12, Vol.42 (6S), p.S2-S6 [Peer Reviewed Journal]FranceFull text available |
17 |
Material Type: Article
|
![]() |
Improving the Flexibility and Efficiency of Phase II Designs for Oncology TrialsEnglert, Stefan ; Kieser, MeinhardBiometrics, 2012-09, Vol.68 (3), p.886-892 [Peer Reviewed Journal]Malden, USA: Blackwell Publishing IncFull text available |
18 |
Material Type: Article
|
![]() |
Atezolizumab (Tecentriq ® ): Activity, indication and modality of use in advanced or metastatic urinary bladder carcinomaBernard-Tessier, Alice ; Bonnet, Clément ; Lavaud, Pernelle ; Gizzi, Marco ; Loriot, Yohann ; Massard, ChristopheBulletin du cancer, 2018-02, Vol.105 (2), p.140 [Peer Reviewed Journal]FranceNo full-text |
19 |
Material Type: Article
|
![]() |
Fresh-Packed RBC Infusion Diminishes Acute AlP Poisoned-Patients' Mortality Rate: A Clinical TrialRahimi, Nastaran ; Behnoush, Behnam ; Hosseini, Hamed ; Fakhrabadi, Amir A ; Javadian, Nina ; Barzegari Dahaj, Nasrin ; Maleki, Adeleh ; Tabatabaei, Seyed Morteza ; Dehpour, Ahmad RezaActa medica Iranica, 2022, Vol.60 (11), p.680 [Peer Reviewed Journal]Tehran: Tehran University of Medical SciencesFull text available |
20 |
Material Type: Article
|
![]() |
Bayesian designs and the control of frequentist characteristics: A practical solutionVentz, Steffen ; Trippa, LorenzoBiometrics, 2015-03, Vol.71 (1), p.218-226 [Peer Reviewed Journal]United States: International Biometric Society, etc.Full text available |